<DOC>
	<DOCNO>NCT00654654</DOCNO>
	<brief_summary>The purpose study evaluate safety profile treatment effect autologous human fibroblast placebo administer facial wrinkle crease</brief_summary>
	<brief_title>Safety Efficacy Study Isolagen TherapyTM Treatment Facial Wrinkles Creases</brief_title>
	<detailed_description />
	<criteria>Male female , least 18 year age High Investigator wrinkle severity assessment score Subject assessment dissatisfaction facial appearance Provide write informed consent comply study requirement Negative pregnancy test screen visit Healthy , nonscarred skin biopsy Low Investigator wrinkle severity assessment score Subject assessment satisfaction facial appearance Physical attribute prevent assessment treatment facial wrinkle Treatment investigational product procedure within 30 day plan participate another clinical trial Previous treatment Isolagen Therapy History active autoimmune disease organ transplantation Diagnosis cancer , receive active treatment History pigmentary disorder affect face Active chronic skin disease Known genetic disorder affect fibroblast collagen Active systemic infection Requires chronic antibiotic steroidal therapy Use certain cosmetic treatment &amp; procedure Use systemic agent increase bleed clot , disorder equate effect Pregnant lactate woman woman try become pregnant Known allergic reaction component study treatment and/or study injection procedure Excessive exposure sun sunburn postauricular area Subject disorder may prevent compliance Subject part study staff , family member friend</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>